Benefits of resection for metachronous lung cancer

Slides:

Advertisements

Similar presentations

Manuel J. Antunes, MD, PhD, DSc

Advertisements

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer? Traves D. Crabtree, MD, Varun Puri,

Lung cancer screening: No more excuses

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

Does the Presence of Preoperative Mild or Moderate Coronary Artery Disease Affect the Outcomes of Lung Transplantation? Cliff K. Choong, FRACS, Bryan.

Survival after resection of synchronous non–small cell lung cancer

Thirteen-year experience in lung transplantation for emphysema

Surgical treatment of metachronous second primary lung cancer after complete resection of non–small cell lung cancer Masatsugu Hamaji, MD, Mark S. Allen,

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer Aalok P. Patel, BS, Traves D. Crabtree,

John M. Varlotto, MD, Abram Recht, MD, John C. Flickinger, MD, Laura N

William M. DeCampli, MD, PhD

Prospective evaluation of patients readmitted after cardiac surgery: Analysis of outcomes and identification of risk factors Hersh S. Maniar, MD, Jennifer.

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

Elizabeth A. David, MD, MAS, Stina W. Andersen, PhD, Laurel A

Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base Kathryn E. Engelhardt,

Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery Pedro J.

STAT3, Cten, and lung cancer: Simultaneous excitement and caution

Yang Zhang, MD, Haiquan Chen, MD, PhD

Outcomes after resection of giant emphysematous bullae

Treatment Outcomes in Stage I Lung Cancer

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

It's not “just a shunt” but sometimes it should be…

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Favorable results after sleeve lobectomy or bronchoplasty for bronchial malignancies Hon-Chi Suen, MBBS, Bryan F Meyers, MD, Tracey Guthrie, BSN, Mary.

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Daniel Kreisel, MD, PhD, Alexander S

A fate worse than death Jennifer S. Lawton, MD

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

Manuel J. Antunes, MD, PhD, DSc

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Outcome of bilateral lung volume reduction in patients with emphysema potentially eligible for lung transplantation Bryan F. Meyers, MD, Roger D. Yusen,

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Multifocal lung cancer within ground glass lesions: Are favorable outcomes consequent to surgical resection or inherent to the disease? Mara B. Antonoff,

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed Melanie P. Subramanian, MD, Varun Puri, MD, MSCI

The future of cardiac surgery training: A survival guide

Hope should not spring eternal

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Comparison of open subxiphoid pericardial drainage with percutaneous catheter drainage for symptomatic pericardial effusion Jerome M McDonald, MD, Bryan.

Therapeutic R2 resection for pleural mesothelioma

“The more things change…”: The challenges ahead

Large clinical databases for the study of lung cancer: Making up for the failure of randomized trials Chi-Fu Jeffrey Yang, MD, Matthew G. Hartwig, MD,

Managing conflicts of interest

Aritoshi Hattori, MD, Kenji Suzuki, MD

More than vital: Who bears the burden?

Energized lung resections

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

Journal changes and initiatives

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

Presentation transcript:

Benefits of resection for metachronous lung cancer Richard J Battafarano, MD, PhD, Seth D Force, MD, Bryan F Meyers, MD, Jennifer Bell, BSN, Tracey J Guthrie, BSN, Joel D Cooper, MD, G.Alexander Patterson, MD The Journal of Thoracic and Cardiovascular Surgery Volume 127, Issue 3, Pages 836-842 (March 2004) DOI: 10.1016/j.jtcvs.2003.08.055

Figure 1 Five-year actuarial survival from the time of the first resection of the entire group stratified by the stage of the primary NSCLC. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 836-842DOI: (10.1016/j.jtcvs.2003.08.055)

Figure 2 Five-year actuarial survival from the time of the second resection of the entire group stratified by the stage of the metachronous NSCLC. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 836-842DOI: (10.1016/j.jtcvs.2003.08.055)

Figure 3 Five-year actuarial survival from the time of the second resection of the entire group stratified by tumor histology. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 836-842DOI: (10.1016/j.jtcvs.2003.08.055)

Figure 4 Five-year actuarial survival from the time of the second resection of the entire group stratified by the interval between resections. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 836-842DOI: (10.1016/j.jtcvs.2003.08.055)